Q: What is Trulicity used for?

Trulicity is used to treat type 2 diabetes mellitus , as well as for the reduction of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Q: How does Trulicity work?

How Trulicity Affects the Body Trulicity belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It acts like a hormone that occurs naturally in the body to help manage blood sugar levels in several ways: Stimulating Insulin: When blood sugar levels rise, such as after a meal, Trulicity prompts the pancreas to release insulin. Insulin helps move sugar from the blood into the cells for energy. Reducing Liver Sugar: It helps stop the liver from making and releasing too much sugar into the bloodstream by suppressing the hormone glucagon. Slowing Digestion: It slows down the process of food leaving the stomach, a process called gastric emptying. This helps prevent blood sugar levels from rising too quickly after eating and can help you feel full for a longer period. Appetite Regulation: By affecting the brain's hunger signals and slowing digestion, it may lead to a decrease in appetite. Because Trulicity primarily triggers insulin release when blood sugar is high, it has a lower risk of causing dangerously low blood sugar ( hypoglycemia ) compared to some other diabetes medications when used on its own.

Q: What are the active ingredients in Trulicity?

The active ingredient in Trulicity is dulaglutide .

Q: What are the side effects of Trulicity?

Common side effects of Trulicity may include: Nausea Diarrhea Vomiting and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Trulicity?

Trulicity belongs to the GLP-1 receptor agonist drug class.

Q: What is the dosage of Trulicity and how do I take it?

How to Use Trulicity Trulicity is administered as an injection under the skin of the abdomen, thigh, or upper arm. It is typically used weekly at any time of day, with or without food. When administering the medication, it is important to: Rotate your injection site with each dose to reduce the risk of skin irritation. Check the liquid in the pen before use; it should be clear and colorless. Do not use the medication if it is cloudy, changed in color, or contains particles. Follow the specific instructions provided with your pen device for proper preparation and disposal. Missed Doses If you miss a dose, take it as soon as you remember if there are several days remaining before your next scheduled dose. If your next dose is due very soon, skip the missed dose and resume your regular weekly schedule. Do not take multiple doses within a short period of each other. Storage and Handling Store unused pens in the refrigerator. If necessary, a pen can be kept at room temperature for a limited time, but it must be protected from light and heat. Do not freeze the medication, and do not use it if it has been frozen.

Q: Is Trulicity safe during pregnancy and breastfeeding?

Pregnancy Research on the effects of Trulicity (dulaglutide) in pregnant women is limited. In animal studies, the medication was associated with adverse effects on fetal development, such as reduced birth weight and skeletal changes. Consequently, Trulicity is typically only recommended during pregnancy if the potential benefit to the mother clearly justifies the risk to the fetus. Because Trulicity remains in the system for several weeks, healthcare providers often suggest discontinuing the medication at least two months before a planned pregnancy. It is important to discuss blood sugar management alternatives with a clinician if you are pregnant or planning to conceive. Breastfeeding It is not yet known if Trulicity passes into human breast milk or what effects it may have on a nursing child. Decisions regarding breastfeeding while using this medication should involve a discussion with a healthcare provider to balance the mother's clinical need for the drug with the potential risks to the infant.

Q: What forms and strengths does Trulicity come in?

Available Forms Trulicity is supplied as a clear, colorless liquid solution for injection under the skin. It is administered via subcutaneous injection in areas such as the abdomen, thigh, or upper arm. The medication is provided in the following formats: Single-dose prefilled pen: A disposable device designed for self-administration. Single-dose prefilled syringe: A disposable syringe containing the medication. Each delivery device is intended for one-time use. After the injection is administered, the device must be disposed of properly in a sharps container.

Q: What is the FDA approval status of Trulicity?

FDA Approval and Indications Trulicity (dulaglutide) was first approved by the U.S. Food and Drug Administration (FDA) in 2014. It is indicated for use in adults and children aged 10 years and older with type 2 diabetes to improve blood sugar (glucose) levels, alongside diet and exercise. Additionally, it is approved for adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors to reduce the risk of major adverse cardiovascular events, such as heart attack or stroke. Boxed Warning The FDA has issued a boxed warning for Trulicity because dulaglutide has been shown to cause thyroid C-cell tumors in animal studies. It is unknown whether Trulicity causes these tumors in humans. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use this medication. Safety Communications and Monitoring The FDA monitors the safety of Trulicity through various reporting systems. Notable regulatory updates and safety signals include: Gastrointestinal Concerns: The FDA has identified potential signals of serious risk for ileus (a condition where the bowel does not move properly) through the FDA Adverse Event Reporting System (FAERS). Suicidal Ideation Evaluation: The FDA has conducted evaluations regarding reports of suicidal thoughts or actions in patients using GLP-1 receptor agonists. While current reviews have not found a clear link, the agency continues to monitor this potential risk. Trulicity is not indicated for the treatment of type 1 diabetes or for patients with diabetic ketoacidosis.

Question 1

What is Trulicity?

Accepted Answer

Trulicity belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It functions by mimicking the action of a hormone that naturally occurs in the body to manage glucose levels.

This medication supports the body's ability to produce insulin in response to elevated blood sugar. It also helps regulate the amount of sugar released by the liver and influences how quickly the stomach empties after eating.

Question 2

What is Trulicity used for?

Accepted Answer

Trulicity is used to treat type 2 diabetes mellitus, as well as for the reduction of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Question 3

How does Trulicity work?

Accepted Answer

How Trulicity Affects the Body

Trulicity belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It acts like a hormone that occurs naturally in the body to help manage blood sugar levels in several ways:

Stimulating Insulin: When blood sugar levels rise, such as after a meal, Trulicity prompts the pancreas to release insulin. Insulin helps move sugar from the blood into the cells for energy.
Reducing Liver Sugar: It helps stop the liver from making and releasing too much sugar into the bloodstream by suppressing the hormone glucagon.
Slowing Digestion: It slows down the process of food leaving the stomach, a process called gastric emptying. This helps prevent blood sugar levels from rising too quickly after eating and can help you feel full for a longer period.
Appetite Regulation: By affecting the brain's hunger signals and slowing digestion, it may lead to a decrease in appetite.

Because Trulicity primarily triggers insulin release when blood sugar is high, it has a lower risk of causing dangerously low blood sugar (hypoglycemia) compared to some other diabetes medications when used on its own.

Question 4

What are the active ingredients in Trulicity?

Accepted Answer

The active ingredient in Trulicity is dulaglutide.

Question 5

What are the side effects of Trulicity?

Accepted Answer

Common side effects of Trulicity may include:

Nausea
Diarrhea
Vomiting
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Trulicity?

Accepted Answer

Trulicity belongs to the GLP-1 receptor agonist drug class.

Question 7

What is the dosage of Trulicity and how do I take it?

Accepted Answer

How to Use Trulicity

Trulicity is administered as an injection under the skin of the abdomen, thigh, or upper arm. It is typically used weekly at any time of day, with or without food.

When administering the medication, it is important to:

Rotate your injection site with each dose to reduce the risk of skin irritation.
Check the liquid in the pen before use; it should be clear and colorless. Do not use the medication if it is cloudy, changed in color, or contains particles.
Follow the specific instructions provided with your pen device for proper preparation and disposal.

Missed Doses

If you miss a dose, take it as soon as you remember if there are several days remaining before your next scheduled dose. If your next dose is due very soon, skip the missed dose and resume your regular weekly schedule. Do not take multiple doses within a short period of each other.

Storage and Handling

Store unused pens in the refrigerator. If necessary, a pen can be kept at room temperature for a limited time, but it must be protected from light and heat. Do not freeze the medication, and do not use it if it has been frozen.

Question 8

Is Trulicity safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Research on the effects of Trulicity (dulaglutide) in pregnant women is limited. In animal studies, the medication was associated with adverse effects on fetal development, such as reduced birth weight and skeletal changes. Consequently, Trulicity is typically only recommended during pregnancy if the potential benefit to the mother clearly justifies the risk to the fetus.

Because Trulicity remains in the system for several weeks, healthcare providers often suggest discontinuing the medication at least two months before a planned pregnancy. It is important to discuss blood sugar management alternatives with a clinician if you are pregnant or planning to conceive.

Breastfeeding

It is not yet known if Trulicity passes into human breast milk or what effects it may have on a nursing child. Decisions regarding breastfeeding while using this medication should involve a discussion with a healthcare provider to balance the mother's clinical need for the drug with the potential risks to the infant.

Question 9

What forms and strengths does Trulicity come in?

Accepted Answer

Available Forms

Trulicity is supplied as a clear, colorless liquid solution for injection under the skin. It is administered via subcutaneous injection in areas such as the abdomen, thigh, or upper arm.

The medication is provided in the following formats:

Single-dose prefilled pen: A disposable device designed for self-administration.
Single-dose prefilled syringe: A disposable syringe containing the medication.

Each delivery device is intended for one-time use. After the injection is administered, the device must be disposed of properly in a sharps container.

Question 10

What is the FDA approval status of Trulicity?

Accepted Answer

FDA Approval and Indications

Trulicity (dulaglutide) was first approved by the U.S. Food and Drug Administration (FDA) in 2014. It is indicated for use in adults and children aged 10 years and older with type 2 diabetes to improve blood sugar (glucose) levels, alongside diet and exercise. Additionally, it is approved for adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors to reduce the risk of major adverse cardiovascular events, such as heart attack or stroke.

Boxed Warning

The FDA has issued a boxed warning for Trulicity because dulaglutide has been shown to cause thyroid C-cell tumors in animal studies. It is unknown whether Trulicity causes these tumors in humans. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use this medication.

Safety Communications and Monitoring

The FDA monitors the safety of Trulicity through various reporting systems. Notable regulatory updates and safety signals include:

Gastrointestinal Concerns: The FDA has identified potential signals of serious risk for ileus (a condition where the bowel does not move properly) through the FDA Adverse Event Reporting System (FAERS).
Suicidal Ideation Evaluation: The FDA has conducted evaluations regarding reports of suicidal thoughts or actions in patients using GLP-1 receptor agonists. While current reviews have not found a clear link, the agency continues to monitor this potential risk.

Trulicity is not indicated for the treatment of type 1 diabetes or for patients with diabetic ketoacidosis.

Question 11

What should I know about Trulicity and weight loss?

Accepted Answer

How Trulicity Affects Weight

Trulicity (dulaglutide) belongs to a class of medications called GLP-1 receptor agonists. While its primary purpose is to lower blood sugar levels in adults with type 2 diabetes, it often leads to weight loss. This occurs because the medication mimics a hormone that regulates appetite and digestion.

The medication helps with weight management in several ways:

Increased Fullness: It signals the brain to feel full more quickly after eating.
Slower Digestion: It slows down the rate at which the stomach empties, which helps you feel satisfied for a longer period.
Reduced Appetite: Many users report a general decrease in hunger and food cravings.

Clinical Evidence

In clinical trials, people taking Trulicity for type 2 diabetes generally lost more weight than those taking a placebo or certain other diabetes medications. The amount of weight lost often depends on the dosage; higher doses of Trulicity are typically associated with greater weight reduction. However, it is important to note that Trulicity is intended to be used alongside a healthy diet and regular exercise.

Important Considerations

Trulicity is not currently approved by the FDA as a weight-loss drug. It is specifically indicated for improving blood sugar control and reducing the risk of major cardiovascular events in adults with type 2 diabetes. Because weight loss is considered a secondary effect, results can vary significantly from person to person. Some individuals may lose a noticeable amount of weight, while others may see little to no change.

Trulicity

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Trulicity

Hospitals.net Disclosure